Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — United States Securities and Exchange Commission & Leerink Partners

15 shared events · Importance 4 · Last updated Aug 07, 2026

Importance
4
Shared Events
15
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
69
Business
United States — United States Securities and Exchange Commission: The SEC declared the registration statement effective, enabling the IPO to proceed, fulfilling its regulatory oversight role.
Leerink Partners: Leerink Partners served as joint book-running manager, benefiting from underwriting fees and strengthening its healthcare franchise.
Aug 05, 2026 · 15 articles
63
Business
United States — United States Securities and Exchange Commission: The SEC declared the registration statements effective, enabling the IPO to proceed. This regulatory action is routine but essential for the offering's completion.
Leerink Partners: Leerink Partners served as a lead book-running manager, generating underwriting revenue and reinforcing its expertise in healthcare IPOs. The deal enhances its reputation in the sector.
Aug 07, 2026 · 8 articles
53
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared the registration statement for Amanat Acquisition Corporation's IPO effective, overseeing the regulatory compliance of the offering.
Leerink Partners: Leerink Partners is acting as the sole bookrunning manager for Amanat Acquisition Corporation's IPO, responsible for managing the offering.
May 19, 2026 · 6 articles
35
Business
United States — United States Securities and Exchange Commission: The SEC reviewed and declared effective Scribe's registration statement, enabling the IPO. Its regulatory oversight is a standard part of the process.
Leerink Partners: Leerink Partners acted as a joint book-running manager for the IPO, earning fees and enhancing its reputation in biotech capital markets.
Jul 06, 2026 · 25 articles
35
Business
United States — United States Securities and Exchange Commission: The SEC declared the registration statement effective, enabling the offering. This is a routine regulatory function with no direct financial impact.
Leerink Partners: Leerink Partners acted as joint bookrunning manager, earning underwriting fees and strengthening its relationship with Kazia. The successful offering enhances its reputation in biotech capital markets.
Jul 20, 2026 · 22 articles
32
Business
United States — United States Securities and Exchange Commission: The SEC oversees the registration and prospectus filing for the offering, ensuring regulatory compliance.
Leerink Partners: Leerink Partners is a joint book-running manager, participating in the offering and earning fees.
Aug 04, 2026 · 6 articles
26
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission is the regulatory body with which Tango Therapeutics filed its shelf registration statement and related prospectus documents for the offering.
Leerink Partners: Leerink Partners is acting as a joint bookrunning manager for the public offering by Tango Therapeutics, assisting in the sale of securities.
Jun 08, 2026 · 8 articles
24
Business
United States — United States Securities and Exchange Commission: A registration statement for Kailera Therapeutics's IPO was filed with the United States — United States Securities and Exchange Commission and became effective.
Leerink Partners: Leerink Partners acted as a joint book-running manager for Kailera Therapeutics's IPO, facilitating the offering and earning underwriting fees.
Apr 16, 2026 · 8 articles
24
Business
United States — United States Securities and Exchange Commission: Trevi Therapeutics' offering is being made pursuant to a shelf registration statement filed with the United States — United States Securities and Exchange Commission.
Leerink Partners: Leerink Partners is acting as a joint book-running manager for Trevi Therapeutics' public offering.
Apr 16, 2026 · 7 articles
21
Business
United States — United States Securities and Exchange Commission: The SEC will receive a registration statement from Quoin Pharmaceuticals for the resale of the securities issued in the private placement.
Leerink Partners: Leerink Partners acted as lead placement agent for the private placement, facilitating the transaction and earning fees.
Aug 28, 2026 · 6 articles
20
Business
United States — United States Securities and Exchange Commission: Neurogene filed a shelf registration statement with the United States — United States Securities and Exchange Commission, which was declared effective, enabling the public offering.
Leerink Partners: Leerink Partners is acting as a joint bookrunning manager for Neurogene's public offering.
Jun 30, 2026 · 6 articles
20
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission received registration statements for the offering, ensuring regulatory compliance.
Leerink Partners: Leerink Partners is acting as an active book-running manager for the initial public offering of Parabilis Medicines.
Jun 10, 2026 · 7 articles
16
Business
United States — United States Securities and Exchange Commission: The SEC is the regulator with which Beta Bionics filed its shelf registration statement and prospectus supplements for the offering, enabling the securities sale.
Leerink Partners: Leerink Partners served as a joint book-running manager for the offering, adding to its healthcare-focused investment banking deal flow.
Sep 15, 2026 · 7 articles
0
Business
Apr 01, 2026 · 6 articles
0
Business
Leerink Partners: Leerink Partners served as exclusive financial advisor to Obsidian Therapeutics, Inc. and acted as a placement agent for the private placement financing.
Apr 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — United States Securities and Exchange Commission and Leerink Partners interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.